908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.
前日終値
$12.05
+$0.50 · +4.33%
時間外
$12.04
−$0.01 · -0.08%
10月9日 19:30 ET
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
53
適正価値
センチメント
49
まちまち
リスク
47
やや高いリスク
モメンタム
55
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.
日中レンジ
現在 $12.05
52週レンジ
現在 $12.05
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(USD) | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 5619.7万 USD | 5963.1万 USD | 5022.9万 USD | 4685.2万 USD | 4220.6万 USD |
| 売上原価 | 2940万 USD | 2970.6万 USD | 2490.7万 USD | 2082.9万 USD | 1897.3万 USD |
| 粗利益 | 2679.7万 USD | 2992.5万 USD | 2532.2万 USD | 2602.3万 USD | 2323.3万 USD |
| 研究開発 | 1380万 USD | 2549.5万 USD | 2190.4万 USD | 1752.6万 USD | 1306.7万 USD |
| 販売・一般管理 | 3717.7万 USD | — | — | 4387.9万 USD | 3223.5万 USD |
| 営業費用 | 5097.7万 USD | 1.07億 USD | 6808万 USD | 6140.5万 USD | 4530.2万 USD |
| 受取利息 | 413.6万 USD | 449.4万 USD | 648万 USD | 203.1万 USD | 54.8万 USD |
| 支払利息 | — | — | 20.1万 USD | 12.9万 USD | 48.6万 USD |
| 減価償却費と償却費 | 446.5万 USD | 468.2万 USD | 238.4万 USD | 161.4万 USD | 92.5万 USD |
| 営業利益 | −2418万 USD | −7671.8万 USD | −4275.8万 USD | −3538.2万 USD | −2206.9万 USD |
| 純利益 | −3663.9万 USD | −7220.6万 USD | −3639.9万 USD | −3356.3万 USD | −2216.9万 USD |
会社概要が更新されました 2026年10月10日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$12.00
下落余地(0.41%)この株式へのエクスポージャーを報告している上場投資信託です。
ARK Genomic Revolution ETFARKG2263.38万1.10%15.57億 USD0.75%$51.30+4.08%
Avantis U.S. Small Cap Value ETFAVUV1127.13万0.04%308.25億 USD0.25%$119.64-0.41%
Vanguard Morningstar Total Stock Market ETFVTI981.46万0.00%2.3兆 USD0.03%$381.94+0.63%
iShares Russell 2000 ETFIWM949.03万0.01%782.66億 USD0.19%$278.94+0.49%
Vanguard Extended Market ETFVXF362.83万0.00%954億 USD0.05%$235+0.80%
iShares Russell 2000 Value ETFIWN335.13万0.02%138.48億 USD0.24%$210.87-0.04%
Schwab U.S. Small-Cap ETFSCHA202.81万0.01%217.28億 USD0.03%$32.79+0.40%
Vanguard Russell 2000 ETFVTWO178.06万0.01%180億 USD0.06%$112.66+0.50%
ARK Genomic Revolution ETFARKG
Avantis U.S. Small Cap Value ETFAVUV
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Extended Market ETFVXF
iShares Russell 2000 Value ETFIWN
Schwab U.S. Small-Cap ETFSCHA
Vanguard Russell 2000 ETFVTWOAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。